Skip to content

News & calendar

news: as of 2026-10-12
What the marks mean

Importance is a model-assigned 1–5 on published stories, not a market forecast.

Impact on a scheduled row is a company-prominence tier (High/Medium from graph centrality and size; Low only on curated minor events), not a magnitude forecast.

An earnings date marked confirmed is company-confirmed by Yahoo Finance; estimated is not yet announced. Unmarked rows carry no recorded provenance.

Economic releases are macro and carry no industry, so they stay in every view. A release with no value has not printed yet and says so rather than showing a zero.

Upcoming events across the tracked universe; past events are archived, with outcomes added where available — curated and cited, never fabricated. A past row without one reads “outcome pending”.

A lock-up or index change row adds one line of arithmetic — shares becoming sellable, or shares index funds must buy, as a share of float — read off the prospectus or the index methodology, with both numbers cited in the row. It states the mechanics, not a price move. A lock-up date derived as IPO + 180 days stays estimated until the company states it.

Ahead

scheduled · today and tomorrow · calendar refreshed 2026-10-12

Mon · 12 Oct · today

Tue · 13 Oct

Behind

published · newest first

Wed · 15 Jul

regulation

09:33
Google News: Novartis

Genentech, Samsung Bioepis, Novartis, Biogen face key antitrust hearing July 28

Novartis, along with Genentech, Samsung Bioepis, and Biogen, faces a key antitrust hearing on July 28.

Markets open original ↗

product

09:22
Google News: Samsung SDI

Samsung SDI to Launch AI-Based ESS Safety Platform by Year-End

Samsung SDI plans to launch an AI-based ESS safety platform by year-end.

Markets open original ↗

partnership

09:10
Google News: Rocket Lab Corporation

Rocket Lab (RKLB) Just Made an $8 Billion Move That Could Reshape Its Future

Rocket Lab reportedly made an $8 billion move that could reshape its future, though the headline does not specify the deal's exact nature.

Markets open original ↗

earnings

07:50
Google News: China Resources Pharmaceutical Group Limited

China Resources Pharmaceutical Group (03320.HK): Kunming Pharmaceutical Group forecasts a net loss attributable to shareholders of RMB 330 million to RMB 400 million for the first half of the year, swinging from profit to loss

Kunming Pharmaceutical Group, part of China Resources Pharmaceutical, forecast a first-half net loss of RMB 330-400 million, swinging from a prior-year profit.

Markets open original ↗

partnership

07:36
Google News: Waters Corporation

SNT Biotech Announces a Partnership with Waters Corporation to Bring the Most Comprehensive FDA-Cleared At-Home HPV Cervical Cancer Screening Tool Available in the U.S. Today to Patients

SNT Biotech announced a partnership with Waters Corporation to bring an FDA-cleared at-home HPV cervical cancer screening tool to patients.

Markets open original ↗

The wire

everything that arrived · 7 days